SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001144204-18-042148
Filing Date
2018-08-06
Accepted
2018-08-06 16:28:27
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM-S-3/A tv500203_s3a.htm S-3/A 156609
2 GRAPHIC tv500203_logo.jpg GRAPHIC 13646
3 EXHIBIT-5 tv500203_ex5.htm EX-5 8599
4 GRAPHIC tv500203_img1.jpg GRAPHIC 19745
5 GRAPHIC tv500203_img2.jpg GRAPHIC 15572
  Complete submission text file 0001144204-18-042148.txt   234169
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-226206 | Film No.: 18995095
SIC: 2836 Biological Products, (No Diagnostic Substances)